0001618835-17-000002.txt : 20170306
0001618835-17-000002.hdr.sgml : 20170306
20170306155534
ACCESSION NUMBER: 0001618835-17-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170302
FILED AS OF DATE: 20170306
DATE AS OF CHANGE: 20170306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neothetics, Inc.
CENTRAL INDEX KEY: 0001618835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208527075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: (858) 750-1008
MAIL ADDRESS:
STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feldman Maria
CENTRAL INDEX KEY: 0001674083
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36754
FILM NUMBER: 17667807
MAIL ADDRESS:
STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-03-02
0
0001618835
Neothetics, Inc.
NEOT
0001674083
Feldman Maria
9171 TOWNE CENTRE DRIVE, SUITE 250
SAN DIEGO
CA
92122
0
1
0
0
VP Clinical Research & Operati
Stock Option (Right to Buy)
1.43
2017-03-02
4
A
0
90000
0
A
2027-03-02
Common Stock
90000
90000
D
(i) One half of the option shares vest upon receipt and completed analysis of LIPO-202 CL-31 trial data and (ii) the remaining one half of the option shares vest at the earlier of (a) 12/31/2017 or (b) upon the event of a change in control.
/s/ Maria Feldman
2017-03-06